Search

Your search keyword '"Miró, José M."' showing total 977 results

Search Constraints

Start Over You searched for: Author "Miró, José M." Remove constraint Author: "Miró, José M."
977 results on '"Miró, José M."'

Search Results

2. Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)

4. The hidden side of infective endocarditis: Diagnostic and management of 500 consecutive cases in noncardiac surgery centers (2009–2018)

5. Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial

7. Major cardiovascular events after COVID-19 in people with HIV

9. Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)

10. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

13. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration

18. Immunological and virological findings in a patient with exceptional post-treatment control: a case report

19. Overview of SARS-CoV-2 infection in adults living with HIV

20. Infective Endocarditis in Patients on Chronic Hemodialysis

21. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

22. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

23. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial

24. Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIV.

25. Clinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureus

26. Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998–2020

27. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

28. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

30. Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).

31. Clinical Characteristics and Outcome of Bloodstream Infections in HIV-Infected Patients with Cancer and Febrile Neutropenia: A Case–Control Study

33. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

37. Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis

38. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

39. Reply to Garcia-Granja et al

40. Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

42. Leishmaniasis and HIV

44. Role of age and comorbidities in mortality of patients with infective endocarditis

45. Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

46. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

47. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

48. Risk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study

49. Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

50. 963. External Validation of the 2023 Duke - International Society for Cardiovascular Infectious Diseases (ISCVID) Diagnostic Criteria for Infective Endocarditis (IE)

Catalog

Books, media, physical & digital resources